R

ROTTEY S.

Last name: ROTTEY S.

2021 (v1)

Publication

Metadata-only

Expected medium- And long-term impact of the COVID-19 outbreak in oncology

Onesti C. E. Tagliamento M. Curigliano G.

No description

Uploaded on: February 11, 2024
2020 (v1)

Publication

Metadata-only

Oncological care organisation during COVID-19 outbreak

Onesti C. E. Rugo H. S. Generali D.

Background COVID-19 appeared in late 2019, causing a pandemic spread. This led to a reorganisation of oncology care in order to reduce the risk of spreading infection between patients and healthcare staff. Here we analysed measures taken in major oncological units in Europe and the USA. Methods A 46-item survey was sent by email to...

Uploaded on: February 11, 2024
2021 (v1)

Publication

Metadata-only

Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer

Schettini F. Giuliano M. Lambertini M.

Anthracyclines are among the most active chemotherapies (CT) in breast cancer (BC). However, cardiotoxicity is a risk and peculiar side effect that has been limiting their use in clinical practice, especially after the introduction of taxanes. Non‐pegylated liposomal doxorubicin (NPLD) has been developed to optimize the toxicity profile induced...

Uploaded on: April 14, 2023